Lindbrook Capital’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$2.85K Sell
92
-4
-4% -$133 ﹤0.01% 2169
2024
Q4
$3.03K Sell
96
-12
-11% -$570 ﹤0.01% 2174
2024
Q3
$6.26K Sell
108
-2
-2% -$98 ﹤0.01% 1916
2024
Q2
$4.46K Buy
110
+11
+11% +$436 ﹤0.01% 2051
2024
Q1
$4.16K Hold
99
﹤0.01% 1977
2023
Q4
$3.79K Buy
99
+24
+32% +$799 ﹤0.01% 2027
2023
Q3
$2.31K Hold
75
﹤0.01% 2071
2023
Q2
$2.37K Buy
75
+9
+14% +$309 ﹤0.01% 2088
2023
Q1
$2.41K Sell
66
-6
-8% -$210 ﹤0.01% 2162
2022
Q4
$2.13K Sell
72
-144
-67% -$4.63K ﹤0.01% 2207
2022
Q3
$8K Buy
216
+148
+218% +$6.78K ﹤0.01% 1459
2022
Q2
$3K Buy
68
+50
+278% +$1.9K ﹤0.01% 1865
2022
Q1
$1K Sell
18
-709
-98% -$36.6K ﹤0.01% 2407
2021
Q4
$53K Buy
727
+709
+3,939% +$58.2K 0.01% 695
2021
Q3
$2K Hold
18
﹤0.01% 1632
2021
Q2
$1K Hold
18
﹤0.01% 1856
2021
Q1
$0 Hold
18
﹤0.01% 1955
2020
Q4
$0 Hold
18
﹤0.01% 1895
2020
Q3
$0 Hold
18
﹤0.01% 1858
2020
Q2
$0 Sell
18
-55
-75% -$865 ﹤0.01% 1911
2020
Q1
$1K Buy
+73
New +$1.19K ﹤0.01% 1598

Other funds holding ASTH

Lindbrook Capital's ASTH Position: Q1 2025 in Review

Lindbrook Capital reduced its Astrana Health (ASTH) stake by 4.2% in Q1 2025, selling an estimated $133 and leaving 92 shares worth $2.85K. The position accounts for ﹤0.01% of the portfolio, ranked #2169.

Lindbrook Capital first reported a position in ASTH in Q1 2020 and has held it in 21 quarters since. The position peaked at $53K in Q4 2021. 168 funds tracked by Wall St. Rank hold ASTH as of Q1 2025.

  • Lindbrook Capital held 92 shares of Astrana Health worth $2.85K as of Q1 2025.
  • Lindbrook Capital sold 4 Astrana Health shares in Q1 2025, an estimated $133.
  • Astrana Health made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2169 holding.
  • Lindbrook Capital first reported a position in Astrana Health in Q1 2020 and has held it in 21 quarters since.
  • Lindbrook Capital's Astrana Health position peaked at $53K in Q4 2021.
  • 168 funds tracked by Wall St. Rank held Astrana Health as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.